Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods

Medical Care

Volumn 48, Issue 11, 2010, Pages 1026-1035

  Roberts, Rebecca R ^a,b   Scott, R Douglas ^c   Hota, Bala ^a,b   Kampe, Linda M ^d   Abbasi, Fauzia ^e   Schabowski, Shari ^a,b   Ahmad, Ibrar ^a   Ciavarella, Ginevra G ^f   Cordell, Ralph ^g   Solomon, Steven L ^g   Hagtvedt, Reidar ^h   Weinstein, Robert A ^a,b  

^a Jr Hospital of Cook County   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c NATIONAL CENTER FOR PREPAREDNESS DETECTION AND CONTROL OF INFECTIOUS DISEASES   (United States)

^d Cermak Health Services   (United States)

^e Fairfax County Public Safety Occupational Health Center   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g CDC   (United States)

^h UNIVERSITY OF ALBERTA   (Canada)

Author keywords

cost analysis; economic methods; healthcare acquired infection

Indexed keywords

ADULT; ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; APACHE; ARTICLE; ATTRIBUTABLE RISK; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEATH; FEMALE; HEALTH CARE; HEALTH CARE ACQUIRED INFECTION; HEALTH CARE COST; HIGH RISK PATIENT; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; LENGTH OF STAY; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOM SAMPLE; SCORING SYSTEM; SENSITIVITY ANALYSIS; SOCIOECONOMICS;

ADULT; COSTS AND COST ANALYSIS; CROSS INFECTION; DRUG COSTS; FEMALE; HOSPITAL COSTS; HOSPITALIZATION; HOSPITALS; HUMANS; INFECTION CONTROL; LENGTH OF STAY; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, ECONOMIC; PROCESS ASSESSMENT (HEALTH CARE); RISK ASSESSMENT; UNITED STATES; YOUNG ADULT;

EID: 78049346289     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3181ef60a2     Document Type: Article

References (62)

1. CDC. Hospitals must make infection control a priority. American Society of Health-System Pharmacists, 2006. Available at: http://www. ashp.org/import/News/HealthSystemPharmacyNews/newsarticle.aspx?id= 2344. Accessed March 6, 2007.
2. Trampuz A, Widmer AF. Hand hygiene: a frequently missed lifesaving opportunity during patient care. Mayo Clin Proc. 2004;79:109-116.
3. Zell BL, Goldmann DA. Healthcare-associated infection and antimicrobial resistance: moving beyond description to prevention. Infect Control Hospital Epidemiol. 2007;28:261-264.
4. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122:160-166.
5. Jarvis WR. The state of the science of health care epidemiology, infection control, and patient safety, 2004. Am J Infect Control. 2004;32:496-503.
6. Anderson DJ, Kirkland KB, Kaye KS, et al. Underresourced hospital infection control and prevention programs: penny wise, pound foolish? Infect Control Hosp Epidemiol. 2007;28:767-773.
7. Perencevich EN, Stone PW, Wright SB, et al. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol. 2007;28:1121-1133.
8. McKibben L, Horan TC, Tokars JI, et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 2005;26:580-587. (Pubitemid 40896149)
9. Pronovost PJ, Goeschel CA, Wachter RM. The wisdom and justice of not paying for "preventable complications." JAMA. 2008;299:2197-2199.
10. Graves N, McGowan JE. Nosocomial infection, the deficit reduction act, and incentives for hospitals. JAMA. 2008;300:1577-1579.
11. Centers for Medicare & Medicaid Services. Federal register, Part II: rules and regulations. Vol 73. College Park, MD, National Archives and Records Administration; 2008:48433-49084. Available at: http://edocket. access.gpo.gov/2008/E8-17914.htm (accessed September 30, 2010).
12. Clements A, Halton K, Graves N, et al. Overcrowding and understaffing in modern health-care systems: key determinants in meticillin-resistant Staph-ylococcus aureus transmission. Lancet Infect Dis. 2008;8:427-434.
13. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA. 1996;275:234-240.
14. Roberts RR, Hota B, Ahmad I, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009;49:1175-1184.
15. Roberts RR, Frutos PW, Ciavarella GG, et al. Distribution of variable vs fixed costs of hospital care. JAMA. 1999;281:644-649.
16. Roberts RR, Scott RD II, Cordell R, et al. The use of economic modeling to determine the hospital costs associated with nosocomial infections. Clin Infect Dis. 2003;36:1424-1432.
17. Blough DK, Ramsey SD. Using generalized linear models to assess medical care costs. Health Serv Outcomes Res Methodol. 2000;1:185-202.
18. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461-494.
19. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ. 1998;17:283-295.
20. Mullahy J. Econometric modeling of health care costs and expenditures: a survey of analytical issues and related policy considerations. Med Care. 2009;47:104-108.
21. Roberts RR, Zalenski RJ, Mensah EK, et al. Costs of an emergency department-based accelerated diagnostic protocol vs hospitalization in patients with chest pain: a randomized controlled trial. JAMA. 1997;278:1670-1676.
22. Roberts RR, Kampe LM, Hammerman M, et al. The cost of care for patients with HIV from the provider economic perspective. AIDS Patient Care STDS. 2006;20:876-886.
23. Elward AM, Hollenbeak CS, Warren DK, et al. Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics. 2005;115:868-872.
24. Cocanour CS, Ostrosky-Zeichner L, Peninger M, et al. Cost of a ventilator-associated pneumonia in a shock trauma intensive care unit. Surg Infect (Larchmt). 2005;6:65-72.
25. Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network (HNSN) Report, data summary for 2006, issued June 2007. Am J Infect Control. 2007;35:290-301.
26. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-140.
27. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619-1636.
28. Wisniewski MF, Kieszkowski P, Zagorski BM, et al. Development of a clinical data warehouse for hospital infection control. J Am Med Inform Assoc. 2003;10:454-462.
29. Finkler SA. Essentials of Cost Accounting for Health Care Organizations. Gaithersburg, MD: Aspen Publishers; 1994.
30. Cosgrove SE, Kaye KS, Eliopoulous GM, et al. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med. 2002;162:185-190.
31. Vincent JL, Bihari DJ, Suter PM, et al. EPIC International Advisory Committee. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA. 1995;274:639-644.
32. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued Oct 2004. Am J Infect Control. 2004;32:470-485.
33. Neuhauser MM, Weinstein RA, Rydman R, et al. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA. 2003;289:885-888.
34. Graves N, Weinhold D, Tong E, et al. Effect of healthcare-acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol. 2007;28:280-292.
35. Chen YY, Chou YC, Chou P. Impact of nosocomial infection on cost of illness and length of stay in intensive care units. Infect Control Hosp Epidemiol. 2005;26:281-287.
36. Orsi GB, Di Stefano L, Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol. 2002;23:190-197.
37. Beyersmann J, Gastmeier P, Grundmann H, et al. Use of multistate models to assess prolongation of intensive care unit due to nosocomial infection. Infect Control Hosp Epidemiol. 2006;27:493-499.
38. Beyersmann J, Wolkewitz M, Schumacher M. The impact of time-dependent bias in proportional hazards modeling. Stat Med. 2008;27: 6439-6454.
39. Wolkewitz M, Vonberg RP, Grundmann H, et al. Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models. Crit Care. 2008;12:R44.
40. Graves N, Weinhold D, Roberts JA. Correcting for bias when estimating the cost of hospital-acquired infection: an analysis of lower respiratory tract infections in non-surgical patients. Health Econ. 2005;14:755-761.
41. Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med. 2008;27:2037-2049.
42. Kurth T, Walker AM, Glynn RJ, et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and property-based weighing under conditions of nonuniform effect. Am J Epidemiol. 2006;163:262-270.
43. Diehr P, Yanez D, Ash A, et al. Methods for analyzing health care utilization and costs. Annu Rev Public Health. 1999;20:125-144.
44. Kleinbaum DG, Kupper LL, Nizam A, et al. Applied Regression Analysis and Other Multivariable Methods. 4th ed. Belmont, CA: Duxbury Press; 2008.
45. Chen CL. An introduction to quantile regression and the QUANTREG procedure. Paper 213-30. SAS Institute Inc. Available at: www2.SAS. com/proceedings/sugi30/213-30.pdf. Accessed May 12, 2009.
46. Thomas WJ, Ward K. Economic profiling of physician specialists: use of outlier treatment and episode attribution rules. Inquiry. 2006;43:271-282.
47. Buckley JA, Georgianna TD. Analysis of statistical outliers with application to whole effluent toxicity testing. Water Environ Res. 2001;73: 575-583.
48. Krautmann AC, Ciecka J. Interpreting the regression coefficient in semilogarithmic functions: a note. Indian J Econ Bus. 2006;5:121-125.
49. Grosse SD. Appendix I: productivity loss tables. In: Haddix AC, Teutsch SM, Corso PS, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. 2nd ed. New York, NY: Oxford University Press; 2003:245-257.
50. Streit JM, Jones RN, Sader HS, et al. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents. 2004;24:111-118.
51. US Department of Commerce. Statistical Abstract of the United States: 2002: The National Data Book. 122nd ed. Washington, DC: US Census Bureau; 2002.
52. Payments on Medical Malpractice, 2008. Kaiser Family Foundation State Health Facts. Available at: http://www.statehealthfacts.org/ comparemaptable.jsp?cat=8&ind=437. Accessed October 10, 2009.
53. Popper KR. Conjectures and Refutations: The Growth of Scientific Knowledge. 5th ed. London, United Kingdom: Routledge & Kegan Paul Plc; 1989.
54. Laupland KB, Lee H, Gregson DB, et al. Cost of intensive care unit-acquired bloodstream infections. J Hosp Infect. 2006;63:124-132.
55. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725-2732.
56. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31:1312-1317.
57. Forster AJ, Clark HD, Menard A, et al. Adverse events among medical patients after discharge from hospital. CMAJ. 2004;170:345-349.
58. Plowman R, Graves N, Griffin MA, et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect. 2001;47:198-209.
59. Butler AM, Olsen MA, Merz LR, et al. Attributable costs of enterococ-cal bloodstream infections in a nonsurgical hospital cohort. Infect Control Hosp Epidemiol. 2010;31:28-35.
60. Trick WE, Zagorski BM, Tokars JI, et al. Computer algorithms to detect bloodstream infections. Emerg Infect Dis. 2004;10:1612-1620.
61. Weinstein JW, Mazon D, Pantelick E, et al. A decade of prevalence surveys in a tertiary-care center: trends in nosocomial infection rates, device utilization, and patient acuity. Infect Control Hosp Epidemiol. 1999;20:543-548.
62. Cummings KL, Anderson DJ, Kaye KS. Hand hygiene noncompliance and the cost of hospital-acquired methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol. 2010;31:357-364.